Professor Saad Shakir is one of the leading experts in Europe in pharmacoepidemiology, pharmacovigilance, risk management and risk minimisation in pharmacovigilance.
Saad worked on major drug safety issues such as product withdrawals an important restrictions. Saad Shakir launches his Consultancy.
Saad provides:
- Consultancy and advice
- Training and Education
- Collaborative projects to advance pharmacovigilance.
Consultancy
Saad Shakir consults on pharmacovigilance, pharmacoepidemiology, PASS studies, Risk Management, Risk Minimisation (including monitoring its effectiveness), Real World Studies, Real World Evidence, Benefit/Fisk evaluation and pharmacvigilance submissions & responses to regulatory authorities.
- Assessment of single and clusters of ADR reports.
- Data Safety Management Boards and Advisory Committees.
- Medicolegal work.
Training and education
I will organise training courses, meetings and conferences on a range of area of pharmacovigilance and pharmacoepidemiology.
Advance pharmacovigilance and patients safety
I will continue my collaborations with colleagues around the world to move pharmacovigilance and patients safety forward.